- Report
- February 2024
- 85 Pages
China
From €4516EUR$4,750USD£3,794GBP
- Report
- April 2023
- 121 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- April 2023
- 111 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- August 2022
- 120 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Drug Pipelines
- July 2022
- 60 Pages
Global
From €2139EUR$2,250USD£1,797GBP
- Report
- January 2024
- 150 Pages
Global
From €4611EUR$4,850USD£3,873GBP
- Report
- May 2024
- 85 Pages
From €3280EUR$3,450USD£2,755GBP
- Report
- January 2024
- 143 Pages
Global
From €4040EUR$4,250USD£3,394GBP
- Report
- January 2024
- 200 Pages
Global
From €3945EUR$4,150USD£3,314GBP
- Report
- January 2024
- 200 Pages
Global
From €3945EUR$4,150USD£3,314GBP
- Report
- October 2021
- 140 Pages
Global
From €3803EUR$4,000USD£3,195GBP
- Report
- April 2023
- 119 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- August 2022
- 120 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- November 2021
- 113 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- January 2018
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- September 2023
- 149 Pages
Europe
From €1426EUR$1,500USD£1,198GBP
- Report
- September 2023
- 130 Pages
North America
From €1426EUR$1,500USD£1,198GBP
- Report
- February 2024
- 140 Pages
Vietnam
From €2651EUR$2,789USD£2,227GBP
- Report
- October 2023
- 140 Pages
Global
From €3421EUR$3,599USD£2,874GBP
- Report
- May 2023
- 147 Pages
Global
From €4705EUR$4,949USD£3,952GBP

The Percutaneous Coronary Intervention (PCI) Device market is a segment of the Cardiovascular Devices market. It includes devices used to treat coronary artery disease, such as balloon catheters, stents, guidewires, and other accessories. These devices are used to open blocked arteries, restore blood flow, and reduce the risk of heart attack. PCI devices are minimally invasive, allowing for faster recovery times and fewer complications than traditional open-heart surgery.
The PCI Device market is driven by the increasing prevalence of cardiovascular diseases, technological advancements, and the growing demand for minimally invasive procedures. The market is further supported by government initiatives to reduce the burden of cardiovascular diseases and the increasing availability of healthcare services.
Some of the major companies in the PCI Device market include Abbott Laboratories, Boston Scientific Corporation, Medtronic, B. Braun Melsungen AG, Terumo Corporation, and Edwards Lifesciences Corporation. Show Less Read more